PXD012676 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Fingolimod and remyelination - Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model |
Description | Remyelinating substances could be an essential supplement to immunomodulatory medications, optimizing the treatment of multiple sclerosis (MS) patients. Fingolimod is a sphingosine-1-phosphate receptor (S1PR) modulator and crosses the blood-brain barrier. Central nervous system (CNS) cells express S1PRs, and Fingolimod could theoretically improve CNS remyelination and be neuroprotective per se, but data are inconsistent. We used the cuprizone model for investigating the effect of fingolimod on remyelination and axonal damage by Immunohistochemistry and quantitative mass spectrometry. After three weeks of remyelination, fingolimod-treated mice had more mature oligodendrocytes in the secondary motor cortex than the placebo group. However, fingolimod did not at any time point affect remyelination or axonal damage. We conclude that fingolimod does not promote remyelination or protect against axonal injury or loss after cuprizone exposure. |
HostingRepository | PRIDE |
AnnounceDate | 2021-03-04 |
AnnouncementXML | Submission_2021-03-04_14:12:03.776.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Eystein Oveland |
SpeciesList | scientific name: Mus musculus (Mouse); NCBI TaxID: 10090; |
ModificationList | TMT6plex-126 reporter+balance reagent acylated residue; monohydroxylated residue; iodoacetamide derivatized residue |
Instrument | Q Exactive |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2019-02-12 05:28:50 | ID requested | |
⏵ 1 | 2021-03-04 14:12:04 | announced | |
Publication List
Nystad AE, Lereim RR, Wergeland S, Oveland E, Myhr KM, B, ø L, Torkildsen Ø, Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model. J Neuroimmunol, 339():577091(2020) [pubmed] |
Keyword List
curator keyword: Biomedical |
submitter keyword: Brain, CPZ, fingolimod, tissue, mouse, mass spectrometry, QE-HF, TMT, proteomics, multiplexing |
Contact List
Frode S. Berven |
contact affiliation | Proteomics unit at the university of Bergen (PROBE), Department of Biomedicine, University of Bergen |
contact email | frode.berven@uib.no |
lab head | |
Eystein Oveland |
contact affiliation | Institute of Marine Research |
contact email | eysteino@gmail.com |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD012676 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD012676
- Label: PRIDE project
- Name: Fingolimod and remyelination - Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model